Cybrexa Therapeutics Alternatives & Competitors
12 companies similar to Cybrexa Therapeutics — Changing the paradigm for cancer treatment through the development of antigen-in...
Affini-T Therapeutics
Right Targets. Right Cells. Right Place. Unlocking the power of T cells against oncogenic...
Watertown, United States
Radionetics Oncology
Discovering and developing novel radiotherapeutics for the treatment of cancer.
San Diego, United States
Incyclix Bio
Regaining Cell Cycle Control
Durham, United States
Ariceum Therapeutics
Developing next-generation radiotherapeutics to visualize and treat cancer
Berlin, Germany
Track all Cybrexa Therapeutics competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Arcellx
Arcellx is a clinical-stage biotechnology company based in Redwood City, California
Redwood City, United Stat...
TORL BioTherapeutics LLC
Advancing novel antibody-based therapies to transform the lives of cancer patients.
Culver City, United State...
Alterome Therapeutics, Inc
To Life!
San Diego, United States
Immatics
The Global Leader in Precision Targeting of PRAME
Germany
T-Therapeutics Ltd
Making T-Cell Receptor Biologics a Reality
Cambridge, United Kingdom
RayzeBio
Targeted innovative radiopharmaceuticals for cancer
San Diego, United States
Brenus Pharma
Next-generation cancer treatment bringing the immune system one step ahead of cancer 🧬🟣
Lyon, France
Adela, Inc.
Advancing the field of epigenomics to transform how cancer is detected and monitored.
Foster City, United State...
About Cybrexa Therapeutics
Changing the paradigm for cancer treatment through the development of antigen-independent peptide drug conjugates.
Development of novel peptide-drug conjugates, Antigen-independent tumor targeting, Phase 1 and Phase 2 clinical trials, Research and development in oncology, Enhancement of existing cancer therapies
Cancer patients, Oncologists, Healthcare providers specializing in oncology, Research institutions
Oncology, Clinical-stage, Peptide Drug Conjugates, Antigen-independent, Tumor Targeting, Drug Development, Cancer Treatment, PHLIP Peptides, Metastatic Cancer, Small Molecule Anti-cancer Agent, Clinical Trials, Management Team, Life Science, Proprietary Technology
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Cybrexa Therapeutics and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Cybrexa Therapeutics on 9 Jun 2026. The 12 companies listed here were last checked between 17 Sep 2025 and 3 Jul 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.